The CARES Initiative: A Global Initiative in Support of the Fight Against HIV & Related Co-Infections
The CARES initiative was launched and driven by a social and civic responsibility to support the fight against HIV/AIDS. Public and private partnerships are being explored to identify areas for Beckman Coulter Life Sciences to contribute for the broader purpose. We seek to develop alliances with non-governmental organizations (NGO’s), implementing partners, and health policy organizations to align our efforts.
Beckman Coulter Life Sciences is meeting tomorrow’s needs today by our commitment to leading the fight against HIV through the development of innovative solutions for the monitoring of CD4+ lymphocyte depletion and viral load levels. Our simple, robust and sustainable tests have been made available to thousands of patients and allow the Health Departments to channel more funds towards better treatment programs.
“We seek alliances with NGO’s, implementing partners, and health policy organizations”
Tiered Laboratory Networks
Laboratories are the backbone of the entire public health system, and standardization is the key to success in order to facilitate collaboration and communication between them.
Within a tiered public healthcare system, near-patient testing in many cases still means high-throughput testing, combined with centralized data collection and storage requirements.
“Within a tiered public healthcare system, near-patient testing in many cases still means high-throughput testing”
While basic peripheral testing sites usually need to rely on Point of Care testing due to infrastructural challenges, all other laboratory categories require state-of-the-art solutions that meet flexible workload requirements and automated integrated approaches.
The 2013 WHO guidelines, and the 2015 revision thereof, call for an earlier treatment with antiretroviral therapy (ART) for people infected with HIV, and identify CD4 count and viral load analysis as the two main technologies to monitor ART treatment initiation and follow-up (3; 6).
“CD4 analysis platforms are needed in both centralized and regional healthcare facilities”
This requires countries to build capacity for the analysis of immune system integrity, and especially for CD4 analysis platforms that can be used in both centralized and regional healthcare facilities. Learn more about the latest WHO Guidelines for HIV Advance Disease Management.
*Photos courtesy of Dr. Charles Kiyaga
- WHO (2015): HIV/AIDS Fact Sheet No. 360. World Health Organization, Geneva.
- UNAIDS (2014): 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, pp. 1-33. 3. WHO (2013): Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infections. World Health Organization, Geneva, pp. 28-30.
- Cassim N et al. (2014): Estimating Implementation and Operational Costs of an Integrated Tiered CD4 Service including Laboratory and Point of Care Testing in a Remote Health District in South Africa. PLoS ONE 9(12): e115420.
- WHO (2015): Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. World Health Organization, Geneva.
REQUEST ADDITIONAL INFORMATION